Cargando...

Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41

Here, we describe the genetic pathways taken by a human immunodeficiency virus type 1 (HIV-1) isolate, D101.12, to become resistant to the small molecule CCR5 inhibitor, vicriviroc (VCV) in vitro. Resistant D101.12 variants contained at least one substitution in the gp120 V3 region (H308P), plus one...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Anastassopoulou, Cleo G., Ketas, Thomas J., Depetris, Rafael S., Thomas, Antonia M., Klasse, Per Johan, Moore, John P.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3070043/
https://ncbi.nlm.nih.gov/pubmed/21356539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2010.12.052
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!